MED COVID-19: Understanding the impact of COVID-19 on cognitive function (Milestone 11.N)
In Progress
Timeline Start - End
2022 - 2029Research Implementation Area
Enabling Technologies and Disease MonitoringAD-Related Dementias Focus
Characterize the clinical phenotype and develop diagnostic criteria for neurocognitive impairment and dementia associated with COVID-19 in those with and without neurocognitive impairment/dementia prior to infection.
Success Criteria
- Develop clinical diagnostic criteria that are specific for incident neurocognitive impairment and dementia associated with long-term outcomes, including temporal progression, following SARS-CoV-2 infection.
Summary of Key Accomplishments
This milestone has just been initiated. Accomplishments are forthcoming.
The key accomplishments summary is current as of November 2022.